Eric Lefkofsky notes growth at major U.S. oncology research event

Eric Lefkofsky notes growth at major U.S. oncology research event
Lefkofsky reports oncology event growth

Research efforts at the U.S. oncology conference continued to evolve as Eric Lefkofsky reported significant expansion during the tenth annual event.

The event saw the largest collection of accepted research to date and record crowds at both the industry expert theater and demonstration stations. Lefkofsky highlighted the organization's progress over the past decade, pointing to increased participation and interest. ''It is incredible to think about how much we have grown since our first,'' Lefkofsky wrote, reflecting on the scale and engagement at this year's conference.

Lefkofsky previously introduced Preview, an AI platform that delivers pathology insights to doctors within 24 hours. Earlier this year, Tempus, the company he leads, received FDA clearance for its tumor-only genomic profiling test. These developments add to the organization's ongoing efforts in oncology research and diagnostics.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.